TELA · TELA Bio, Inc.
$0.64
-0.03 (-4.97%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued. Accordingly, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$28.93M
Shares
44.89M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Antony Koblish | President and Chief Executive Officer | $2,399,605 |
| Maarten Persenaire | Chief Medical Officer | $907,671 |
| E. Skott Greenhalgh | Chief Technology Officer | $844,917 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Antony Koblish | President and Chief Executive Officer | $568,903 |
| Maarten Persenaire | Chief Medical Officer | $410,010 |
| E. Skott Greenhalgh | Chief Technology Officer | $402,950 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Heather Getz | Class II director | Appointed | 2026-08-04 |
| Heather Getz | Chief Executive Officer | Appointed | 2026-08-04 |
| Antony Koblish | member of the Board | Resigned | 2026-08-04 |
| Antony Koblish | Chief Executive Officer | Terminated | 2026-08-04 |
| William Plovanic | Class I director | Appointed | 2026-06-11 |
| Betty Jo Rocchio | Class I director | Appointed | 2026-06-11 |
| Joseph Capper | Class I director | Appointed | 2026-06-11 |
| Federica O’Brien | Board | Resigned | 2026-04-30 |
| Vince Burgess | Board | Resigned | 2026-04-30 |
| Kurt Azarbarzin | Board | Resigned | 2026-04-30 |
| Doug Evans | Chairman of the Board of Directors | Retired | 2026-04-30 |
| William Plovanic | Class I director | Appointed | 2025-11-03 |
| Dr. Betty Jo Rocchio | member of the Board | Appointed | 2025-10-09 |
| Lisa Colleran | member of the Board of Directors | Resigned | 2025-10-09 |
| Jeffrey Blizard | President | Appointed | 2025-06-02 |
| Jeffrey Blizard | member of the Board of Directors | Resigned | 2025-06-02 |
| Vince Burgess | Class III director | Appointed | 2025-05-30 |
| Federica O'Brien | Class III director | Appointed | 2025-05-30 |
| Jeffrey Blizard | Class III director | Appointed | 2025-05-30 |
| Jeffrey Blizard | member of the Company's Board of Directors | Appointed | 2024-06-06 |
| John Nosenzo | member of the Board of Directors | Resigned | 2023-09-28 |
Key facts
CIK
1561921
CUSIP
872381108
13F (30d)
46 filings
44 filers
Visit website
Investor relations